CIK 0001607962
- Non-accelerated filer
- Smaller reporting company
Lifeward Ltd.
Sign in to watch- Ticker
- LFWD
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +1 508-251-1154
- Business address
- 2 CABOT ROAD, HUDSON, MA, 01749
- Former names
- ReWalk Robotics Ltd., Argo Medical Technologies Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-02 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award | +60,000 | 64,995 | ||
| 2019-06-07 | Koren Ofir Snr VP, R&D and Regulatory | Sale | −100 | $6.50 | $650 | 5,253 |
| 2019-06-07 | Koren Ofir Snr VP, R&D and Regulatory | Sale | −108 | $6.52 | $704 | 5,145 |
| 2019-06-07 | Koren Ofir Snr VP, R&D and Regulatory | Sale | −150 | $6.51 | $977 | 4,995 |
| 2019-06-01 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award | +3,750 | 5,353 | ||
| 2018-05-03 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award | +13,125 | 40,091 | ||
| 2018-05-03 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award · Option (Right to buy) | +65,625 | 65,625 | ||
| 2017-10-05 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award | +13,401 | 26,966 | ||
| 2017-10-04 | Koren Ofir Snr VP, R&D and Regulatory | Returned to the company · Option (Right to buy) | −5,657 | 0 | ||
| 2017-10-04 | Koren Ofir Snr VP, R&D and Regulatory | Returned to the company · Option (Right to buy) | −25,000 | 0 | ||
| 2017-10-04 | Koren Ofir Snr VP, R&D and Regulatory | Returned to the company · Option (Right to buy) | −17,950 | 0 | ||
| 2017-04-18 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award | +7,500 | 13,565 | ||
| 2017-04-18 | Koren Ofir Snr VP, R&D and Regulatory | Grant or award · Option (Right to buy) | +37,500 | 37,500 | ||
| 2017-01-06 | Koren Ofir Snr VP, R&D and Regulatory | Exercise or conversion | +4,720 | $1.32 | $6K | 10,785 |
| 2017-01-06 | Koren Ofir Snr VP, R&D and Regulatory | Sale | −4,720 | $3.50 | $17K | 6,065 |
| 2017-01-06 | Koren Ofir Snr VP, R&D and Regulatory | Exercise or conversion · Option (Right to buy) | −4,720 | 3,310 | ||
| 2017-01-03 | Koren Ofir Snr VP, R&D and Regulatory | Exercise or conversion | +500 | $1.32 | $660 | 6,565 |
| 2017-01-03 | Koren Ofir Snr VP, R&D and Regulatory | Sale | −500 | $3.00 | $2K | 6,065 |
| 2017-01-03 | Koren Ofir Snr VP, R&D and Regulatory | Exercise or conversion · Option (Right to buy) | −500 | 8,030 | ||
| 2016-05-18 | Koren Ofir Snr VP, Research & Development | Grant or award | +3,350 | 6,065 |
Page 1 of 2 · 21 trades